ACMG's Genetics in Medicine Journal Receives Record High Impact Factor of 7.329 for 2014: GIM Now in Top 4% of Indexed Journals

News provided by

American College of Medical Genetics and Genomics

Jul 30, 2015, 11:40 ET

BETHESDA, Md., July 30, 2015 /PRNewswire-USNewswire/ -- The American College of Medical Genetics and Genomics (ACMG) announced that the Thomson Reuters Impact Factor Journal Citation Reports has just increased the impact factor of the ACMG's peer-reviewed medical genetics and genomics journal, Genetics in Medicine (GIM) to 7.329 in 2014, up from 6.435 in 2013. GIM is currently ranked 15 of 167 titles in the Genetics & Heredity category and in the very top echelon of genetic journals that have a primarily clinical focus. A journal's Impact Factor is an objective measure of the world's leading journals, based on articles' cited references and is oft considered a measure of a journal's overall successful performance and relevance to its field.

"We're delighted that our impact factor has jumped again this year, placing Genetics in Medicine in the top 4% of all indexed journals. This increase is a testament to the vibrancy of the field of Medical Genetics as a whole and its increasing importance to medical practitioners in every specialty of Medicine," said GIM's Editor-in-Chief Jim Evans, MD, PhD, FACMG.

"The continued progress in GIM's impact is also indicative of the American College of Medical Genetics and Genomics' relevance to the broader medical community," added Evans.

Gerald Feldman, MD, PhD, FACMG and president of the ACMG said, "Congratulations to Dr. Jim Evans and the entire editorial team at Genetics in Medicine. This is a very rewarding rise in our Impact Factor. As a leading academic medical journal, we know that GIM will continue to play an essential role in setting the standard for the practice of medical genetics and genomics in patient care."

Genetics in Medicine is published by Nature Publishing Group (www.nature.com/gim)

The journal, published since 1998, is supported by an expert Board of Editors representing all facets of genetic and genomic medicine, including such specialties as biochemical genetics, cytogenetics and pharmacogenetics.

About the American College of Medical Genetics and Genomics (ACMG) and ACMG Foundation
Founded in 1991, ACMG is the only nationally recognized medical society dedicated to improving health through the clinical practice of medical genetics and genomics. The American College of Medical Genetics and Genomics (www.acmg.net) provides education, resources and a voice for nearly 1800 biochemical, clinical, cytogenetic, medical and molecular geneticists, genetic counselors and other healthcare professionals, nearly 80% of whom are board certified in the medical genetics specialties. The College's mission is to develop and sustain genetic initiatives in clinical and laboratory practice, education and advocacy. Three guiding pillars underpin ACMG's work: 1) Clinical and Laboratory Practice: Establish the paradigm of genomic medicine by issuing statements and evidence-based or expert clinical and laboratory practice guidelines and through descriptions of best practices for the delivery of genomic medicine. 2) Education: Provide education and tools for medical geneticists, other health professionals and the public and grow the genetics workforce. 3) Advocacy: Work with policymakers and payers to support the responsible application of genomics in medical practice. Genetics in Medicine, published monthly, is the official ACMG peer-reviewed journal. ACMG's website (www.acmg.net) offers a variety of resources including Policy Statements, Practice Guidelines, Educational Resources, and a Find a Geneticist tool. The educational and public health programs of the American College of Medical Genetics are dependent upon charitable gifts from corporations, foundations, and individuals through the ACMG Foundation for Genetic and Genomic Medicine (www.acmgfoundation.org.)

SOURCE American College of Medical Genetics and Genomics